Development of O-specific polysaccharide-protein conjugates is based upon the protective effect of serum vibriocidal antibodies against cholera
- 1 October 1995
- journal article
- Published by Elsevier in Bulletin de l'Institut Pasteur
- Vol. 93 (4) , 269-272
- https://doi.org/10.1016/0020-2452(96)85761-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Vibrio cholerae O139 in Thailand in 1994Epidemiology and Infection, 1995
- Antibodies to Lipopolysaccharides after Immunization of Humans with the Rough Mutant Escherichia coli J5The Journal of Infectious Diseases, 1991
- Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccinesVaccine, 1990
- Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-upThe Lancet, 1990
- Seroepidemiological Studies of EI Tor Cholera in Bangladesh: Association of Serum Antibody Levels with ProtectionThe Journal of Infectious Diseases, 1985
- Duration of Infection-Derived Immunity to CholeraThe Journal of Infectious Diseases, 1981
- Response of Man to Infection with Vibrio cholerae. I. Clinical, Serologic, and Bacteriologic Responses to a Known InoculumThe Journal of Infectious Diseases, 1974
- Cholera Reinfection in ManThe Journal of Infectious Diseases, 1971
- The Antigens of Vibrio cholerae Involved in the Vibriocidal Action of Antibody and ComplementThe Journal of Infectious Diseases, 1970
- The 1968-1969 Cholera-Vaccine Field Trial in Rural East Pakistan. Effectiveness of Monovalent Ogawa and Inaba Vaccines and a Purified Inaba Antigen, with Comparative Results of Serological and Animal Protection TestsThe Journal of Infectious Diseases, 1970